Global Cardiac Safety Services Market
Healthcare Services

Cardiac Safety Services Industry Expansion Forecast Showing Market Size of $1.93 Billion by 2030 at 10.7% CAGR

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Cardiac Safety Services Market During The Forecast Period 2026–2030?

The cardiac safety services market size has seen rapid expansion in recent years. Its projected growth will be from $1.16 billion in 2025 to $1.29 billion in 2026, at a compound annual growth rate (CAGR) of 10.6%. During the historic period, this growth was driven by factors including increasing complexity of clinical trial protocols, rising regulatory scrutiny on cardiac safety, growth in early-phase drug development activity, increased incidence of drug-induced cardiotoxicity concerns, and the expansion of outsourcing to specialized service providers.

The cardiac safety services market is projected to experience significant expansion in the coming years. It is anticipated to reach $1.94 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This anticipated growth during the forecast period is fueled by several factors, including a surge in demand for integrated cardiac safety platforms, the increasing uptake of remote monitoring technologies, the broadening scope of decentralized clinical trials, an intensified focus on predictive cardiac safety analytics, and greater investment in advanced cardiac biomarkers. Key trends during this period encompass a rise in the use of centralized ECG monitoring services, an escalating need for real-time telemetry within clinical trials, the expanding application of advanced cardiac imaging for drug safety, the broadening of thorough QT study mandates, and a heightened emphasis on early-stage cardiac risk evaluation.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10137&type=smp

What Underlying Factors Are Accelerating The Growth Of The Cardiac Safety Services Market?

The expanding aging population is projected to stimulate the growth of the cardiac safety services market. An aging population is characterized by a higher median age, resulting from diminished fertility rates and extended life expectancy. With an older demographic, there is a rise in the prevalence of cardiovascular diseases, thereby escalating the demand for cardiac safety services. Elderly individuals necessitate specialized management and care for geriatric syndromes within cardiac intensive care units, an area where cardiac safety services prove beneficial. As an illustration, data from January 2024 provided by the US-based Population Reference Bureau indicates that the number of Americans aged 65 and older is forecasted to increase from 58 million in 2022 to 82 million by 2050, marking a 47% rise. Over this identical timeframe, their proportion within the overall population is also predicted to expand from 17% to 23%. Consequently, the increasing aging population is a significant driver for the expansion of the cardiac safety services market.

What Market Segments Are Evaluated Within The Cardiac Safety Services Market?

The cardiac safety services market covered in this report is segmented –

1) By Services: ECG Or Holter Measurements, Blood Pressure Measurements, In Vitro Cardiac Safety Assessment Services, Cardiovascular Imaging, Real-Time Telemetry Monitoring, Central Over-Read Of ECGS, Non-Invasive Cardiac Imaging, Physiologic Stress Testing, Thorough QT Studies

2) By Phase: Phase 1, Phase 2, Phase 3

3) By End User: Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institute

Subsegments:

1) By ECG Or Holter Measurements: Standard ECG Monitoring, 24-Hour Holter Monitoring, Event Monitoring

2) By Blood Pressure Measurements: Continuous Blood Pressure Monitoring, Ambulatory Blood Pressure Monitoring, In-Hospital Blood Pressure Measurements

3) By In Vitro Cardiac Safety Assessment Services: Cardiomyocyte Toxicity Testing, Cardiac Ion Channel Testing, Mechanistic Studies

4) By Cardiovascular Imaging: Echocardiography, MRI Imaging, CT Angiography

5) By Real-Time Telemetry Monitoring: Remote Patient Monitoring, Continuous Telemetry Services

6) By Central Over-Read Of ECGs: ECG Interpretation Services, Quality Control And Reporting

7) By Non-Invasive Cardiac Imaging: Stress Testing, Nuclear Cardiology

8) By Physiologic Stress Testing: Exercise Stress Testing, Pharmacologic Stress Testing

9) By Thorough QT Studies: Clinical Trial Services, Safety Assessments For Drug Development

What Key Developments And Trends Are Impacting The Cardiac Safety Services Market?

Major companies in the cardiac safety services market are channeling their efforts into introducing next-generation solutions, such as AI and ML-driven cardiac safety tools, to gain a competitive advantage. These tools process ECG data to offer detailed information regarding the acquired continuous ECG data, including an assessment of its quality. The AI and ML algorithms are trained using extensive datasets of ECG information to ensure accurate and trustworthy outcomes. For instance, in November 2023, Clario, a US-based healthcare company, introduced its new AI-powered ECG quality score tool aimed at improving cardiac safety assessments. This particular tool employs a unique method of machine learning and artificial intelligence to elevate the standard of cardiac safety data. Sponsors can leverage this practical intelligence to implement proactive corrections and achieve certainty regarding data quality. An artificial intelligence (AI) tool further enhances Clario’s leading Early Precision QT (EPQT) early phase solution, which could potentially allow for the waiver of conventional Thorough QT (TQT) investigations.

Who Are The Top Market Participants Influencing The Cardiac Safety Services Market?

Major companies operating in the cardiac safety services market are Laboratory Corporation of America Holdings, Banook Group Limited, Pharmaceutical Product Development LLC, Biotrial S.A., Certara Inc., Celerion Inc., Medpace Holdings Inc., Ncardia AG, Richmond Pharmacology Limited, SGS Société Générale de Surveillance SA, Clario, Eurofins Scientific SE, Spaulding Clinical Research LLC, ERT Inc., IQVIA Holdings Inc., Bioclinica Inc., ICON plc, BioTelemetry Inc., PPD Inc., Parexel International Corporation, Chiltern International Limited, Biomedical Systems, High Point Clinical Trials Center, Maastricht University Medical Centre+, CCBR-SYNARC, Medicalgorithmics S.A., Advarra Inc.

Read the full cardiac safety services market report here:

https://www.thebusinessresearchcompany.com/report/cardiac-safety-services-global-market-report

Which Region Is Projected To Dominate The Cardiac Safety Services Market During The Forecast Period?

North America was the largest region in the cardiac safety services market in 2025. The regions covered in the cardiac safety services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cardiac Safety Services Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10137&type=smp

Browse Through More Reports Similar to the Global Cardiac Safety Services Market 2026, By The Business Research Company

Heart Blocks Treatment Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/heart-blocks-treatment-devices-global-market-report

Cardiac Pacemakers Global Market Report

https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report

Implantable Heart Pacemaker Global Market Report

https://www.thebusinessresearchcompany.com/report/implantable-heart-pacemaker-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model